tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oncolytics initiated with a Buy at Lake Street
PremiumThe FlyOncolytics initiated with a Buy at Lake Street
28d ago
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
Premium
Ratings
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
28d ago
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
Premium
Ratings
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
28d ago
Oncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
PremiumCompany AnnouncementsOncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
1M ago
Oncolytics Biotech Files SEC Report Incorporating Information Circular
Premium
Company Announcements
Oncolytics Biotech Files SEC Report Incorporating Information Circular
1M ago
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
Premium
The Fly
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
1M ago
Oncolytics Biotech Engages FDA for Pivotal Pancreatic Cancer Study
PremiumCompany AnnouncementsOncolytics Biotech Engages FDA for Pivotal Pancreatic Cancer Study
1M ago
Oncolytics engaging FDA for registration-enabled pancreatic cancer trial
Premium
The Fly
Oncolytics engaging FDA for registration-enabled pancreatic cancer trial
1M ago
Buy Rating for Oncolytics Biotech Driven by Promising Pelareorep Data in Pancreatic and Colorectal Cancers
Premium
Ratings
Buy Rating for Oncolytics Biotech Driven by Promising Pelareorep Data in Pancreatic and Colorectal Cancers
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100